ActoGeniX N.V.

2 clinical trials · Sponsor

Record	Firm	Date
Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck (NCT00938080)	ActoGeniX N.V.	2009-09-01
A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis (NCT00729872)	ActoGeniX N.V.	2008-07-01

Every clearance here is in the API, with alerts when new ones post.